Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients

by Sophie A. Kurk, Petra H.M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Hugo J. Kuijf, Cornelis J.A. Punt, Miriam Koopman, Anne M. May
Published 2018-10-01

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy

by Willemieke P.M. Dijksterhuis, Maarten J. Pruijt, Stephanie O. van derWoude, Remy Klaassen, Sophie A. Kurk, Martijn G.H. vanOijen, Hanneke W.M. vanLaarhoven
Published 2019-02-01

The association between changes in muscle mass and quality of life in patients with metastatic colorectal cancer

by Jeroen W.G. Derksen, Sophie A. Kurk, Petra H.M. Peeters, Bram Dorresteijn, Marion Jourdan, Ankie M.T. van derVelden, Peter Nieboer, Robert S. deJong, Aafke H. Honkoop, Cornelis J.A. Punt, Miriam Koopman, Anne M. May
Published 2020-08-01

Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial

by Sophie A. Kurk, Petra H. M. Peeters, Bram Dorresteijn, Pim A. deJong, Marion Jourdan, Geert‐Jan M. Creemers, Frans L. G. Erdkamp, Felix E. deJongh, Peter A. M. Kint, Boelo J. Poppema, Sandra A. Radema, Lieke H. J. Simkens, Bea C. Tanis, Manuel L. R. Tjin‐A‐Ton, Ankie Van Der Velden, Cornelis J. A. Punt, Miriam Koopman, Anne M. May
Published 2020-02-01